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Over the years, literally dozens of inter-
ventions have been proposed to prevent
hospital-acquired pneumonia. Most hos-
pitals have combined a subset of these
practices into “ventilator bundles” that
are mandatory for all mechanically venti-
lated patients and sometimes all critically
ill patients. Typical bundle elements in-
clude elevation of the head of the bed,
routine oral carewith chlorhexidine, daily
sedative interruptions, daily assessment
of readiness to extubate, deep venous
thrombosis prophylaxis, and stress ulcer
prophylaxis. Bundles vary broadly, how-
ever, from hospital to hospital [1].
Despite the popularity and broad pen-
etration of ventilator bundles, the evi-
dencesupportingeachbundlecomponent
is highly variable. Some components,
such as routine sedative interruptions
and daily assessments of readiness to ex-
tubate, have been well studied and consis-
tently associated with better outcomes
[2–5]. Other components, such as head-
of-bed elevation, have only been assessed
in few patients [6, 7]. Finally, there are
many successful interventions to prevent
pneumonia that are not part of most hos-
pitals’ bundles [8].
A systematic review and meta-analysis
in this issue of Clinical Infectious Diseases
helpfully summarizes some of the vast lit-
erature on preventing hospital-acquired
pneumonia and provides some clarity
about the relative value of different inter-
ventions. Roquilly and colleagues identi-
ﬁed 157 randomized controlled trials
evaluating more than 20 different inter-
ventions. They conducted a series of
meta-analyses to determine the impact
of each intervention. The investigators se-
lected hospital mortality as their primary
outcome rather than hospital-acquired
pneumonia. Of the 20 interventions stud-
ied, the only measure associated with a
decreaseinhospitalmortalitywasselective
digestive decontamination with regimens
that included systemic antimicrobials
(relative risk, 0.78, 95% conﬁdence inter-
val, .69–.89). Patient positioning, subglottic
secretion drainage, closed suctioning sys-
tems, probiotics, early tracheotomy, early
enteral feeding, stress ulcer prophylaxis,
silver-coated endotracheal tubes, oral de-
contamination with antiseptics or antibiot-
ics, selective digestive decontamination
without systemic antimicrobial therapy,
and all the other interventions studied
had no impact on mortality.
These provocative ﬁndings are a shot
over the bow of infection prevention and
quality improvement programs. This
meta-analysis simultaneously challenges
the validity of current ventilator bundles
and begsthe question whyselective diges-
tive decontamination with systemic anti-
microbials is not routinely employed?
In truth, evidence has been gathering
for years that the classic ventilator bundle
m e r i t sr e v i s i o n .S o m eb u n d l ec o m p o -
nents, such as stress ulcer prophylaxis,
paradoxically increase pneumonia risk
[9]. Other bundle components, such as
routine oral care with chlorhexidine, do
not clearly prevent ventilator-associated
pneumonia and may even increase mor-
tality risk [10, 11].
A major challenge in pneumonia pre-
vention science is the subjectivity and
poor speciﬁcity of clinical criteria to de-
ﬁne pneumonia [12, 13]. Subjectivity
allows for the possibility that lower pneu-
monia rates in the treatment arms of
open-label studies are due to observer
bias. Poor speciﬁcity allows for the possi-
bility that some of the decreases in pneu-
monia rates in both open-label and
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nization rather than less pneumonia [14].
These challenges are the reasons why
Roquilly and colleagues selected mortality
as their primary outcome rather than
hospital-acquired pneumonia. Other work-
ers have reached similar conclusions [14–
16]. Indeed, the Society of Healthcare
Epidemiologists of America and Infec-
tious Disease Society of America’sl a t e s t
revision of their compendium of strategies
to prevent ventilator-associated pneumo-
nia speciﬁcally prioritizes interventions as-
sociated with less time to extubation,
shorter intensive care stays, lower hospital
mortality, less antibiotic prescribing, and/
or lowercosts over interventions associated
with lower ventilator-associated pneumo-
nia rates alone [17]. The compendium
recommends using noninvasive mechani-
cal ventilation whenever possible, mini-
mizing sedation, interrupting sedatives
and assessing readiness to extubate daily,
mobilizing patients early, using endotra-
cheal tubes with subglottic secretion
drainage, changing ventilator circuits
only if visibly soiled or malfunctioning,
and elevating the head of the bed.
Thisbundleofrecommendationsisdif-
ferent and more extensive than those sug-
gested by the meta-analysis by Roquilly
and colleagues. There are 2 reasons for
this. First, the compendium authors eval-
uated some interventions that were not
considered by Roquilly and colleagues
such as noninvasive positive pressure
ventilation, minimizing sedation, daily
sedative interruptions, and daily assess-
ment of readiness to extubate. Second,
the compendium authors found merit
in interventions associated with less
time to extubation, shorter lengths-of-
stay, less antibiotic prescribing, and/or
lowercosts in addition to those associated
with lower mortality rates. This is impor-
tant, partly because these are additional
clinically meaningful outcomes, and
partly because the amount of evidence
supporting different interventions varies
considerably. Some interventions, such
as oral and digestive decontamination,
have been studied in literally tens of thou-
sands of patients whereas other inter-
ventions, such as elevating the head of
the bed, have only been studied in a few
hundred patients. Most small studies
lack adequate power to detect changes
in mortality rates but can sometimes
show positive effects on other outcomes.
Most strikingly, however, despite
acknowledging that selective digestive
decontamination is one of the only pneu-
monia prevention practice associated
with lower mortality rates, the compendi-
um authors downgraded this measure to
a “special practice.” Special practices are
recommended only for units with persis-
tently high ventilator-associated pneumo-
nia rates despite high rates of adherence
to the strategies suggested above. In doing
so, the compendium authors echoed the
concerns of many North American practi-
tionerswhofearthatwidespreaduseofan-
tibiotics for digestive decontamination will
ultimately increase antibiotic resistance
and Clostridium difﬁcile infections, partic-
ularly in North American hospitals where
drug resistance is more prevalent than in
Northern Europe. These practitioners fear
thatthe deleterious consequences of multi-
drug resistance will ultimately outweigh
any short-term mortality gain associated
with digestive decontamination.
And indeed, resistome analyses of the
gut ﬂora of individual patients assigned
to digestive decontamination do reveal
progressive selection for antimicrobial re-
sistance [18, 19]. At the population level,
however, the data on resistance are more
ambiguous. A recent meta-analysis of
35 studies found no difference between
decontamination patients and control
patients in the frequency of colonization
or infection with methicillin-resistant
Staphylococcus aureus, vancomycin-
resistant enterococci, aminoglycoside-
resistant Gram-negative bacilli, or ﬂuoro-
quinolone-resistant Gram-negative bacilli
[20]. Remarkably, decontamination was
associated with less Gram-negative bacilli
resistant to third-generation cephalospo-
rins or polymyxins.
These ﬁndings ﬂy in the face of ecolog-
ical studies associating greater antibiotic
prescribing with greater rates of antibiotic
resistance [21, 22]. Multiple explanations
have been proposed [20]. Some suggest
that lowering infection rates overall may
decrease the absolute incidence of drug-
resistant infections even if the proportion
ofdrug-resistantpathogensmaybehigher.
Others have noted that in many studies
(but not all) patients randomized to de-
contamination ended up receiving fewer
antibiotics in total compared to control
patients perhaps because therewere fewer
new infections to treat.
A recurring critique of the decontami-
nation literature is that most studies only
followed a limited number of patients for
a limited period of time. Observational
data are now accruing, however, that the
mortality beneﬁt of digestive decontami-
nation may be sustained and that low
rates of antibiotic resistance can persist
for years [23, 24].
As an infectious disease physician, I am
instinctively uncomfortable with digestive
decontamination with systemic antimicro-
bials. I focus muchof my clinical work and
teaching on encouraging clinicians to use
antimicrobials as judiciously as possible.
Nonetheless,wecannotignoretheaccumu-
lating evidence on digestive decontamina-
tion. There are precious few interventions
in critical care associated with a 22% mor-
tality reduction. And we must admit that
there are other areas of infectious disease
practice where we’ve come to accept rou-
tine antimicrobial prophylaxis (eg, bone
marrow transplants, surgical prophylaxis,
human immunodeﬁciency virus with low
CD4counts).Itbehoovesusnowtoconduct
the deﬁnitive studies of digestive decon-
tamination in North America with long-
enough follow-up periods to settle the
question for once and for all of the relative
beneﬁts and risks of routine digestive de-
contamination. We owe it to our patients.
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